Theodore I. Steinman

Active 1977–2025

Also published as
THEODORE I. STEINMAN
40
Papers
20,564
Citations
32
h-index
38
i10-index

Citations

Citations per year for Theodore I. Steinman1978: 1 citations1979: 1 citations1980: 3 citations1982: 1 citations1985: 4 citations1986: 4 citations1987: 4 citations1988: 5 citations1989: 9 citations1990: 7 citations1991: 13 citations1992: 14 citations1993: 12 citations1994: 22 citations1995: 13 citations1996: 11 citations1997: 16 citations1998: 14 citations1999: 16 citations2000: 21 citations2001: 20 citations2002: 31 citations2003: 64 citations2004: 105 citations2005: 177 citations2006: 194 citations2007: 212 citations2008: 223 citations2009: 244 citations2010: 233 citations2011: 220 citations2012: 223 citations2013: 210 citations2014: 156 citations2015: 121 citations2016: 112 citations2017: 127 citations2018: 104 citations2019: 399 citations2020: 391 citations2021: 356 citations2022: 214 citations2023: 139 citations2024: 256 citations2025: 113 citations2026: 1 citations1981: no citations, so this year is not shown1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,164 citing papers, 29.5% of this breakdownUnited Kingdom: 472 citing papers, 6.4% of this breakdownItaly: 371 citing papers, 5.1% of this breakdownCanada: 357 citing papers, 4.9% of this breakdownChina: 334 citing papers, 4.5% of this breakdownGermany: 331 citing papers, 4.5% of this breakdownNetherlands: 307 citing papers, 4.2% of this breakdownFrance: 301 citing papers, 4.1% of this breakdownAustralia: 270 citing papers, 3.7% of this breakdownJapan: 264 citing papers, 3.6% of this breakdownSpain: 196 citing papers, 2.7% of this breakdownBelgium: 155 citing papers, 2.1% of this breakdown
0%29.5%Other 24.7%

Fields

  • Medicine75.5%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Engineering1.4%
  • Health Professions1.1%
  • Nursing1%
  • Immunology and Microbiology0.9%
  • Other3%

Topics

  • Chronic Kidney Disease and Diabetes10.7%
  • Dialysis and Renal Disease Management9.8%
  • Parathyroid Disorders and Treatments3.8%
  • Acute Kidney Injury Research3.3%
  • Renal and related cancers3.1%
  • Genetic and Kidney Cyst Diseases3.1%
  • Other66.2%

Coauthors

All papers

Open in search
  1. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Garabed Eknoyan, Nathan W. Levin, S Burrows-Hudson, William F. Keane, Alan S. Kliger, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Kerry Willis, George R. Bailie, Gavin J. Becker, Jerrilynn D. Burrowes, David Churchill, Alan Collins, William Couser, Dick de Zeeuw, Alan J. Garber, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Joel Greer, Richard H. Grimm, Ramon G. Hannah, Jaime Herrera Acosta, Ronald J. Hogg, Lawrence G. Hunsicker, Michael J. Klag, Saulo Klahr, C. Lewis, Edmund G. Lowrie, Arthur Matas, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, William F. Owen, Thakor G. Patel, Glenda M. Payne, Rosa A. Rivera-Mizzoni, David L. Smith, Robert A. Star, Theodore I. Steinman, Fernando Valderrábano, John Walls, Jean Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs - 2002 cited by 11,656

  2. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 cited by 774

  3. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2021 cited by 168

  4. The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study

    Authors: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2018 cited by 203

  5. Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 517

  6. Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2017 cited by 173

  7. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD

    Authors: , , , , , , , , , , , , , , , , , - JCI Insight 2020 cited by 86

  8. A method for estimating nitrogen intake of patients with chronic renal failure

    Authors: , , - Kidney International 1985 cited by 786

  9. Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 286

  10. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 182

  11. Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , - Kidney International 2019 cited by 78

  12. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dick de Zeeuw, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Roger Greenwood, Joel Greer, Richard H. Grimm, William E. Haley, Ronald J. Hogg, Alan R. Hull, Lawrence G. Hunsicker, Cynda Ann Johnson, Michael J. Klag, Saulo Klahr, Norbert Lameire, Francesco Locatelli, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, Gregorio T. Obrador, William F. Owen, Thakor G. Patel, Glenda M. Payne, Claudio Ronco, Rosa A. Rivera-Mizzoni, Anton C. Schoolwerth, Robert A. Star, Michael W. Steffes, Theodore I. Steinman, John Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs, Thomas H. Hostetter, Garabed Eknoyan, Aderra Levin, Nathan W. Levin, Sharon Andreoli, S Burrows-Hudson, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Brian J.G. Pereira, Nadine Ferguson, Donna Fingerhut, Anthony Gucciardo, Margaret Klette, Doreen Mallard, Kerry Willis - 2003 cited by 2,538

  13. Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2014 cited by 125

  14. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease

    Authors: , , , , , , , , , , , , , , - Kidney International 2016 cited by 106

  15. Analysis of baseline parameters in the HALT polycystic kidney disease trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2011 cited by 88

  16. Mineral bone disease in autosomal dominant polycystic kidney disease

    Authors: , , , , , , , , , , , , , , , , - Kidney International 2020 cited by 29

  17. Health-Related Quality of Life in Patients With Autosomal Dominant Polycystic Kidney Disease and CKD Stages 1-4: A Cross-sectional Study

    Authors: , , , , , , , , , , , , , - American Journal of Kidney Diseases 2013 cited by 111

  18. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.

    Authors: , , , , , , , , - Journal of the American Society of Nephrology 1995 cited by 251

  19. Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Kidney360 2020 cited by 40

  20. Pain management in polycystic kidney disease

    Authors: , , , - Kidney International 2001 cited by 152

  21. The HALT Polycystic Kidney Disease Trials

    Authors: , , , , , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2010 cited by 145

  22. Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2022 cited by 21

  23. Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies

    Authors: , , , , , , , , , , , , , , - Kidney Medicine 2021 cited by 17

  24. Utility of Radioisotopic Filtration Markers in Chronic Renal Issufficiency: Simultaneous Comparison of 125I-Iothalamate, 169Yb-DTPA, 99mTc-DTPA, and Inulin

    Authors: , , , , , , - American Journal of Kidney Diseases 1990 cited by 311